- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 86.62M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 86.43M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 80.35M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $17.6M |
| Capex | Q1 2025 · Mar 31, 2024 | $20M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2025 | −$29.3M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$94M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.3B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.06B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $123.4M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $38.1M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $23.9M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$862.3M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$711.9M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$529.7M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$490.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $869.1M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $863.6M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.44B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.22B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $917.9M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $766M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.82B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.76B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.87 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.51 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.87 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.51 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $12.1M |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $23.3M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$162M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$41.6M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$48.7M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $36.3M |
| Gross Profit | Q1 2025 · Mar 31, 2025 | −$81.4M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $78.5M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $1.08B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $927.3M |
| Revenue | Q1 2025 · Mar 31, 2025 | $993.9M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.01B |